期刊文献+

陷阱受体3反义寡核苷酸对胶质瘤U251细胞凋亡的影响 被引量:1

Effect of DcR3 antisense oligonucleotides on apoptosis of glioma cells
原文传递
导出
摘要 目的观察陷阱受体3(DcR3)反义核苷酸(ASODN)在胶质瘤细胞凋亡中的作用。方法构建并挑选DcR3反义核苷酸,转染U251细胞,逆转录-聚合酶链反应(RT—PCR)、Western blot方法观察DcR3 mRNA和蛋白有无降低,流式细胞仪观察细胞凋亡的变化。结果经1.2μmol/L AS20DN处理的U251细胞可有效地降低DcR3 mRNA和蛋白表达,DcR3/β-actin比值分别为(12.4±3.1)%和(13.5±4.2)%,错义链组、脂质体组、对照组mRNA和蛋白分别为(68.8±4.5)%、(74.5±5.0)%、(71.3±6.4)%和(78.2±6.8)%、(79.8±4.5)%、(76.4±5.6)%,差异有统计学意义(P〈0.05),同时,传染DcR3反义核苷酸的U251细胞凋亡率为(42.9±13.1)%,明显高于错义链组(15.8±4.8)%、脂质体组(15.7±3.7)%和对照组(14.6±4.0)%,差异有统计学意义(P〈0.05)。结论DcR3反义核苷酸可使U251细胞凋亡增多。 Objective To explore the effect of DcR3 antisense oligonucleotides on apoptosis of glioma ceils. Methods After constructing and choosing DcR3 antisense oligonucleotides and transfecting glioma cell lines U251 ,we detected the DcR3 mRNA and protein expression by RT-PCR and Western blot assays,and observed the apoptosis by flow cytometry. Results 1.2 μmol/L DcR3 antisense oligonucleotides could effectively reduce the expression of DcR3 mRNA and protein ( P 〈 0.05 ) with the ratio of DcR3/β-actin being ( 12.4 ± 3. 1 ) % and ( 13.5 ± 4.2 ) % respectively. In the SC, LFA, and control groups,the expression of DeR3 mRNA and protein was (68.8 ± 4.5 )%, (74.5 ±5. 0)%, (71.3± 6.4 ) %, and (78.2 ± 6.8 ) %, ( 79.8± 4.5 ) %, ( 76.4± 5.6 ) % respectively. The apoptosis rate in glioma cells transfected with DcR3 antisense oligonucleotides was (42.9 ± 13.1 )% ,significantly higher than ( 15.8 ± 4.8 ) %, ( 15.7 ± 3.7) %, ( 14.6± 4.0) % respectively in the SC, LFA, and control groups ( P 〈 0.05). Conclusion DcR3 antisense oligonucleotides could induce apoptosis of glioma cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第1期67-69,共3页 Chinese Journal of Experimental Surgery
关键词 反义寡核苷酸 胶质瘤 脱噬作用 Antisense oligonueleotide Glioma Apoptosis
  • 相关文献

参考文献10

  • 1Nishizaki T, Ozaki S, Harada K, et al. Investigation of genetic alteration associated with the grade of astrocytic tumor by comparative genomi hybridization. Genes Chromosomes Cancer, 1998,21:340-346.
  • 2Pitti RM, Marsters SA, Lawrence DA, et al. Genormic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 1998,396:699-703.
  • 3Chang YC, Chan YH, Jackson DG, et al The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion. J Immunol,2006,176 : 173-180.
  • 4Yang CR, Hsieh SL,Teng CM, et al. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1 A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Research ,2004,64 : 1122-1129.
  • 5马廉亭.脑胶质瘤实验研究的现状与展望[J].中华实验外科杂志,2001,18(6):490-490. 被引量:16
  • 6黄强,浦佩玉,夏之柏,蒋元文,尤永平,张云亭,王春燕,王广秀.连接蛋白43联合自杀基因治疗胶质瘤的研究[J].中华实验外科杂志,2003,20(3):285-285. 被引量:6
  • 7Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand ( DcR3 ) in patients with gastric carcinomas. Gastric Cancer,2002,5:61-68.
  • 8Ohshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for fas ligand ( DcR3 ) in virus ( EBV or HTLV-Ⅰ) associated lymphomas. Cancer letters ,2000,160 : 89-97.
  • 9Shoichiro T, Ryo H, Shin Y, et al. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma, international journal of cancer. J Internat Cancer, 2003,106 : 17 -25.
  • 10Roth W,Isenmann S, Nakamura M, et al. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res,2001,61:2759-2765.

共引文献18

同被引文献9

  • 1Pitti RM, Marsters SA, Lawrence DA, et al. Genormic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 1998,396:699-703.
  • 2Chang YC, Chan YH, Jackson DG,et al The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monoeyte adhesion. J Immunol,2006,176 : 173-180
  • 3Yang CR, Hsieh SL, Teng CM, et al. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1 A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Research, 2004,64 : 1122-1129.
  • 4Dexeus FH, Logothetic CJ, Samaels ML, et al. Complete response in meastatis transitional cell carcinoma of the prostate with cisplat in regiments. J Urol, 1987,137 : 122-127.
  • 5Wilfried R, Stdan I, Nakamura M, et al. Soluble decoy receptor 3 is expressed by malignant glionms and suppresses CD95 liganfinduced apoptosis and chemotaxis. Cancer Res,2001,61:2759-2765.
  • 6Shoichiro T, Hosotani R, Yonehara S, et al. Endogenous decoy receptor 3 blocks the groth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer,2003,106 : 17-25.
  • 7Wu YI, Bing H, Sheng H,et al. Clinical significance of detecring elevated serum DcR3/TR6/M68 in malignant tumor patients. Int J Cancer,2003,105:724-732.
  • 8Gabriele M, Felix B, Boula JL, et al. DcR3 locus is a predictive marker for 5-fluorouracil based adjuvant ehemotherpy in eolorectal cancer. Int J Cancer,2002,102:254-257.
  • 9马廉亭.脑胶质瘤实验研究的现状与展望[J].中华实验外科杂志,2001,18(6):490-490. 被引量:16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部